Drug Profile
KP 1461
Alternative Names: KP-1461; SN-1461Latest Information Update: 21 Aug 2015
Price :
$50
*
At a glance
- Originator Koronis Pharmaceuticals
- Class Antiretrovirals; Deoxyribonucleosides; Small molecules
- Mechanism of Action HIV replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Suspended HIV infections
Most Recent Events
- 21 Oct 2010 Pharmacodynamics data from a phase IIa trial in HIV infections presented at the 48th Annual Meeting of the Infectious Diseases Society of America (IDSA-2010)
- 29 Apr 2010 KP 1461 is available for licensing as of 29 Apr 2010. http://www.koronispharma.com
- 27 Jun 2007 Phase-II clinical trials in HIV infections in USA (PO)